Trial
NCT02608905
Effect of Dapagliflozin on Inflammation and Endothelial Function
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
—
Condition
Type 2 Diabetes Mellitus
Intervention
Dapagliflozin
Why stopped
Due to difficulty with enrollment of subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-08